Epilepsy Talk

Senators Thrash BIG Pharma CEOs for Pricing Drugs Higher in the U.S.

February 12, 2024
Leave a Comment

One in four Americans can’t afford their prescription drugs.

No big surprise.

Price are higher than any other wealthy nation.

Here are some stunning examples: Johnson & Johnson’s arthritis drug Ustekinumab (Stelara) costs $79,000 in the U.S.

But it costs $20,000 in Canada and $12,000 in France.


Mail-Order Meds — Savings and Service

November 20, 2022
6 Comments

For some people, accessing the pharmacy remains one of the biggest barriers to retrieving prescriptions.

A lack of social support, time constraints and limited access to convenient transportation are commonly cited as reasons users cannot get their medication, according to the Centers for Disease Control and Prevention.

But it’s not just patients who have difficulty getting to the pharmacy who benefit from mail-order pharmacies: These programs offer flexibility, time and cost-savings to all enrolled.


When Your Meds Cost More Than You Can Afford — AED Drug Assistance Programs

April 27, 2021
9 Comments

Today, things are constantly changing.

Especially when it comes to epilepsy medications and resources.

Some companies have expanded their programs or even offer new ones.

Others have cut their funds, and sadly others have ceased to exist.

Here’s a new and comprehensive list…


    About the author

    Phylis Feiner Johnson

    Phylis Feiner Johnson

    I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

    View Full Profile →

    To receive Epilepsy Talk articles FREE, simply go to the bottom of the right column, enter your email address and click on "Follow"

    Join 3,108 other subscribers
    Follow Epilepsy Talk on WordPress.com